StockNews.AI
ELAN
Benzinga
104 days

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

1. ELAN reported Q1 2025 EPS of 37 cents, up 9% year over year. 2. Sales hit $1.19 billion, beating management guidance and consensus estimates. 3. Pet Health revenue declined 1%, but organic growth showed resilience. 4. ELAN raised 2025 revenue guidance to $4.51-$4.58 billion due to strong Q1 performance. 5. Second-quarter EPS guidance is lower than consensus, reflecting caution in forecasts.

5m saved
Insight
Article

FAQ

Why Bullish?

ELAN's strong earnings beat expectations, indicating positive market momentum.

How important is it?

Positive earnings and revenue growth may enhance investor sentiment toward ELAN.

Why Short Term?

Immediate gains due to Q1 results; caution in future guidance may temper longer gains.

Related Companies

Related News